Summary

Biomedical researchers who protested that their fields were slighted in a proposed reorganization of the National Institutes of Health's (NIH's) peer-review system are winning at least some concessions. Responding to the complaints, NIH's Panel on Scientific Boundaries for Review last week penciled in changes to its blueprint that will give heightened prominence to AIDS, urological, and development research. It also made clear that further fine-tuning is likely before it issues its final "Phase 1" report on the overall structure of the peer-review system in January.